AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,892 | +68.0% | 22,805 | +81.2% | 0.00% | – |
| Q2 2023 | $20,769 | +1.8% | 12,587 | -29.7% | 0.00% | – |
| Q1 2023 | $20,406 | -58.0% | 17,900 | -66.8% | 0.00% | – |
| Q4 2022 | $48,632 | +131.6% | 53,910 | +198.5% | 0.00% | – |
| Q3 2022 | $21,000 | -73.4% | 18,063 | -85.3% | 0.00% | – |
| Q2 2022 | $79,000 | -51.8% | 123,295 | +96.7% | 0.00% | – |
| Q1 2022 | $164,000 | -80.1% | 62,690 | -70.4% | 0.00% | – |
| Q4 2021 | $824,000 | +25.6% | 211,768 | +40.6% | 0.00% | – |
| Q3 2021 | $656,000 | +120.9% | 150,611 | +101.1% | 0.00% | – |
| Q2 2021 | $297,000 | -67.8% | 74,900 | -57.8% | 0.00% | – |
| Q1 2021 | $923,000 | +24.6% | 177,563 | +28.3% | 0.00% | – |
| Q4 2020 | $741,000 | +17.6% | 138,354 | +6.8% | 0.00% | – |
| Q3 2020 | $630,000 | +98.7% | 129,592 | +99.0% | 0.00% | – |
| Q2 2020 | $317,000 | +1278.3% | 65,127 | +513.1% | 0.00% | – |
| Q1 2020 | $23,000 | -94.9% | 10,622 | -58.8% | 0.00% | – |
| Q3 2018 | $451,000 | – | 25,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |